000			01997 a2200577 4500
005			20250516064707.0
264		0	_c20120216
008			201202s 0 0 eng d
022			_a1524-4539
024	7		_a10.1161/CIRCULATIONAHA.111.047100 _2doi
040			_aNLM _beng _cNLM
100	1		_aOrbe, J
245	0	0	_aMatrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism. _h[electronic resource]
260			_bCirculation _cDec 2011
300			_a2909-19 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aBleeding Time
650	0	4	_aBrain Ischemia _xdrug therapy
650	0	4	_aCarotid Artery Diseases _xdrug therapy
650	0	4	_aCerebral Hemorrhage _xmetabolism
650	0	4	_aCerebral Infarction _xdrug therapy
650	0	4	_aDisease Models, Animal
650	0	4	_aExtracellular Matrix _xmetabolism
650	0	4	_aFemale
650	0	4	_aFibrinolysis _xdrug effects
650	0	4	_aFibrinolytic Agents _xpharmacology
650	0	4	_aHumans
650	0	4	_aIntracranial Thrombosis _xdrug therapy
650	0	4	_aMale
650	0	4	_aMatrix Metalloproteinase 10 _xgenetics
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMice, Mutant Strains
650	0	4	_aStroke _xdrug therapy
650	0	4	_aThrombin _xmetabolism
650	0	4	_aTissue Plasminogen Activator _xpharmacology
700	1		_aBarrenetxe, J
700	1		_aRodriguez, J A
700	1		_aVivien, D
700	1		_aOrset, C
700	1		_aParks, W C
700	1		_aBirkland, T P
700	1		_aSerrano, R
700	1		_aPurroy, A
700	1		_aMartinez de Lizarrondo, S
700	1		_aAngles-Cano, E
700	1		_aPáramo, J A
773	0		_tCirculation _gvol. 124 _gno. 25 _gp. 2909-19
856	4	0	_uhttps://doi.org/10.1161/CIRCULATIONAHA.111.047100 _zAvailable from publisher's website
999			_c21331653 _d21331653